Continuation of study: Effects of new leukaemia drug on myeloid leukocytes and lymphocytes
Development of new therapeutic agents based on natural product
mutations in calreticulin gene in cases of AML and MPS
Design and synthesis of new anticancer agents for the treatment of Leukaemia
Studies towards the asymmetric synthesis of novel antimitotic agents
Effects of a new class of leukaemia drug on normal myeloid leukocytes and lymphocytes
Studying the problem of relapses within the central nervous system in children with acute lymphoblastic leukaemia (ALL)
Self-esteem and children with CNS tumours
Placement Student Bursary
Developing Vascular Targeting Agents as a Method Combating Childhood cancers
0161 295 3864 